BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31071225)

  • 41. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy.
    Muñoz-Félix JM; López-Novoa JM; Martínez-Salgado C
    Kidney Int; 2014 Feb; 85(2):319-32. PubMed ID: 23945497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
    Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
    Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TNF-alpha neutralization ameliorates obstruction-induced renal fibrosis and dysfunction.
    Meldrum KK; Misseri R; Metcalfe P; Dinarello CA; Hile KL; Meldrum DR
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1456-64. PubMed ID: 17170233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ulinastatin inhibits unilateral ureteral obstruction-induced renal interstitial fibrosis in rats via transforming growth factor β (TGF-β)/Smad signalling pathways.
    Ning XH; Ge XF; Cui Y; An HX
    Int Immunopharmacol; 2013 Feb; 15(2):406-13. PubMed ID: 23318600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defect in Runx2 gene accelerates ureteral obstruction-induced kidney fibrosis via increased TGF-β signaling pathway.
    Kim JI; Jang HS; Jeong JH; Noh MR; Choi JY; Park KM
    Biochim Biophys Acta; 2013 Oct; 1832(10):1520-7. PubMed ID: 23639629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous urokinase lacks antifibrotic activity during progressive renal injury.
    Yamaguchi I; Lopez-Guisa JM; Cai X; Collins SJ; Okamura DM; Eddy AA
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F12-9. PubMed ID: 17356128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Upregulated expression of transforming growth factor-beta, type IV collagen, and plasminogen activator inhibitor-1 mRNA are decreased after release of unilateral ureteral obstruction.
    Ogata Y; Ishidoya S; Fukuzaki A; Kaneto H; Takeda A; Ohyama C; Orikasa S; Arai Y
    Tohoku J Exp Med; 2002 Jul; 197(3):159-68. PubMed ID: 12365557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein restriction ameliorates renal tubulointerstitial nephritis and reduces renal transforming growth factor-beta expression in unilateral ureteral obstruction.
    Sawashima K; Mizuno S; Mizuno-Horikawa Y; Kudo T; Kurosawa T
    Exp Nephrol; 2002; 10(1):7-18. PubMed ID: 11803200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin E ameliorates renal fibrosis in ureteral obstruction: role of maintaining BMP-7 during epithelial-to-mesenchymal transition.
    Tasanarong A; Kongkham S; Thitiarchakul S; Eiam-Ong S
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S10-8. PubMed ID: 22619901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta.
    Wright EJ; McCaffrey TA; Robertson AP; Vaughan ED; Felsen D
    Lab Invest; 1996 Feb; 74(2):528-37. PubMed ID: 8780170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LSKL, a peptide antagonist of thrombospondin-1, attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction.
    Xie XS; Li FY; Liu HC; Deng Y; Li Z; Fan JM
    Arch Pharm Res; 2010 Feb; 33(2):275-84. PubMed ID: 20195829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The antifibrotic effect of a serine protease inhibitor in the kidney.
    Morinaga J; Kakizoe Y; Miyoshi T; Onoue T; Ueda M; Mizumoto T; Yamazoe R; Uchimura K; Hayata M; Shiraishi N; Adachi M; Sakai Y; Tomita K; Kitamura K
    Am J Physiol Renal Physiol; 2013 Jul; 305(2):F173-81. PubMed ID: 23698112
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nrf2 signaling attenuates epithelial-to-mesenchymal transition and renal interstitial fibrosis via PI3K/Akt signaling pathways.
    Wang J; Zhu H; Huang L; Zhu X; Sha J; Li G; Ma G; Zhang W; Gu M; Guo Y
    Exp Mol Pathol; 2019 Dec; 111():104296. PubMed ID: 31449784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clusterin attenuates the development of renal fibrosis.
    Jung GS; Kim MK; Jung YA; Kim HS; Park IS; Min BH; Lee KU; Kim JG; Park KG; Lee IK
    J Am Soc Nephrol; 2012 Jan; 23(1):73-85. PubMed ID: 22052058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tenascin-C Is a Major Component of the Fibrogenic Niche in Kidney Fibrosis.
    Fu H; Tian Y; Zhou L; Zhou D; Tan RJ; Stolz DB; Liu Y
    J Am Soc Nephrol; 2017 Mar; 28(3):785-801. PubMed ID: 27612995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction.
    Beghdadi W; Madjene LC; Claver J; Pejler G; Beaudoin L; Lehuen A; Daugas E; Blank U
    Kidney Int; 2013 Aug; 84(2):317-26. PubMed ID: 23515052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.
    Yan J; Zhang Z; Yang J; Mitch WE; Wang Y
    J Am Soc Nephrol; 2015 Dec; 26(12):3060-71. PubMed ID: 26032813
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction.
    Yoo KH; Thornhill BA; Forbes MS; Coleman CM; Marcinko ES; Liaw L; Chevalier RL
    Kidney Int; 2006 Nov; 70(10):1735-41. PubMed ID: 17003824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis.
    Jiao B; An C; Tran M; Du H; Wang P; Zhou D; Wang Y
    Front Immunol; 2021; 12():735014. PubMed ID: 34512669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metformin Prevents Renal Fibrosis in Mice with Unilateral Ureteral Obstruction and Inhibits Ang II-Induced ECM Production in Renal Fibroblasts.
    Shen Y; Miao N; Xu J; Gan X; Xu D; Zhou L; Xue H; Zhang W; Lu L
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26805826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.